Bromsulphthalein retention test and gamma-glutamyl transpeptidase activity in the investigation of liver disease.
The usefulness of serum gamma-glutamyl transpeptidase activity (gammaGT) was studied in 39 patients on whom a bromsulphthalein retention test (BSP) was performed. In most patients, the potentially hazardous BSP test did not give any further evidence of hepatic disease over conventional hepatic function tests and the gammaGT.
Bromsulphthalein retention test and gamma-glutamyl transpeptidase activity in the investigation of liver disease. The usefulness of serum gamma-glutamyl transpeptidase activity (gammaGT) was studied in 39 patients on whom a bromsulphthalein retention test (BSP) was performed. In most patients, the potentially hazardous BSP test did not give any further evidence of hepatic disease over conventional hepatic function tests and the gammaGT.